Strategic therapy

Cassian Yee, immunotherapy researcher

Ice crystals like powdered sugar audibly crunch as Cassian Yee pulls a long steel box out of a subzero freezer. Wearing bulky blue gloves to protect his hands, he gently extracts from the box a vial the size of a chess piece. A patient's precious T-cells are frozen inside, cells that may halt her advanced skin cancer.

Yee is on the cutting edge of a field known as adoptive immunotherapy. It's one of many unexpected breakthroughs to emerge from the bone-marrow transplantation treatments pioneered by the Hutchinson Center's Dr. E. Donnall Thomas to cure leukemia and other blood cancers. By extracting rare cancer-fighting T-cells from the blood, multiplying them in the lab, and transplanting them back into the body, Yee and his colleagues are using adoptive immunotherapy to harness the power of the immune system to seek and destroy solid tumor cells.

"By creating 'armies' of T-cells that are augmented to find and kill cancer cells, we are aiming to develop a new generation of cancer treatments that can have better results and far fewer side effects for patients than current chemotherapy drugs or radiation treatments," Yee said.

His research was among the first to show that adoptive T-cell therapy holds great promise for treating melanoma, a potentially fatal form of skin cancer. He is also optimistic that he can develop the therapy to treat women with advanced ovarian cancer. In recognition of the potential for his research, Yee received a prestigious five-year grant from the Burroughs Wellcome Fund in 2006 to refine the therapy and improve its tumor-fighting ability.

While his success with melanoma has been a major advance in T-cell therapy, Yee is the first to acknowledge that, like the long games of chess he plays with his son, perfecting the treatment will be an incremental process.

"I tell my son, Nathaniel, that in a slow chess game he must stay focused and that every move on the board can affect the outcome," Yee said. "This is how I view the development of T-cell therapy. We are making step-by-step advances that take time, but our progress is steadily improving a treatment that could save many lives."

Fred Hutchinson Cancer Research Center
1100 Fairview Ave. N. PO Box 19024 Seattle, WA 98109
©2009 Fred Hutchinson Cancer Research Center, a nonprofit organization.
Terms of Use & Privacy Policy.

CenterNetCheck E-mail